AI Governance for Biomedical Translational Research

Led by Gonzalo Izaguirre, PhD, Insight-DNA helps biomedical institutions govern the development and deployment of their AI Machine Learning systems.

Email Gonzalo Try the Assistant

For biomedical institutions adopting AI/ML systems

Most Biomedical AI/ML Models Fail After Deployment

The reason is not technical. It is Governance

Most AI models in biomedical research fail after deployment because of a lack of proper governance.

Costly Late Failure:
Preclinical failure: $500K – $3M
Late candidate attrition: $5M – $50M
Regulatory setbacks: >$10M

Governance failures are rarely visible until critical decisions have already been made

Ask yourself:

Has this model been independently validated?
Who is accountable for its decisions?
Is performance monitored after deployment?

If you can't answer these questions, your institution is at

Risk of Costly Late ML Model Failure

Get Your AI Governance Risk Score

Answer a short set of questions to receive your risk score and governance gap profile immediately

Request Your Risk Score

Executive Workshop for Biomedical AI Governance

Build AI-literate leadership and reduce institutional risk before failure happens. Gain the frameworks, oversight strategies, and governance tools needed to evaluate machine learning responsibly across research, clinical, and translational environments.

Participants leave with an AI Governance Readiness Scorecard and a practical institutional roadmap.

Download the Workshop Brochure

AI Governance Services

Establish control over how AI influences decisions.
We design and implement institutional governance systems that validate models, monitor performance, and ensure accountability across the entire AI lifecycle.

Biomedical Machine Learning Models Fail Because of Gaps in AI Governance

Download the White Paper

AI Governance for Biomedical Institutions That Cannot Afford Failure

Download the Service Document

Gonzalo Izaguirre, PhD

Recent Publications

The FEBS Journal, 2025: Exosites: beyond the limitations of the protease active site.
DOI: 10.1111/febs.70057

Int. J. Mol. Sci., 2025: The Allosteric Communication Network in the Activation of Antithrombin by Heparin.
DOI: 10.3390/ijms26188984

Int. J. Mol. Sci., 2025: Dysregulation of FURIN and Other Proprotein Convertase Genes in the Progression from HPV Infection to Cancer.
DOI: 10.3390/ijms26020461

Try the Insight-DNA Assistant

You can explore our Assistant directly in ChatGPT:

Open in ChatGPT

If you don’t have a ChatGPT account, contact us directly by email.